Overview The Consortium for Clinical Research and Innovation, Singapore (CRIS) brings together seven national R&D, clinical translation and service programmes to advance clinical research and innovation for Singapore, and establish important capabilities for a future-ready healthcare system. The Business Entities under CRIS include: Singapore Clinical Research Institute (SCRI) National Health Innovation Centre (NHIC) Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) Precision Health Research, Singapore (PRECISE) Singapore Translational Cancer Consortium (STCC) Cardiovascular Disease National Collaborative Enterprise (CADENCE) SIngapore Medical FOundation AI model (SIMFONI)
Together, CRIS makes a positive difference to Singapore patients and researchers by ensuring that these clinical research platforms and programmes are at the cutting edge of capability development and innovation. If you are as passionate as we are in clinical trials and research, we want you! The Si...